Skip to main content
Aura Biosciences, Inc. logo

Aura Biosciences, Inc. — Investor Relations & Filings

Ticker · AURA ISIN · US05153U1079 US Manufacturing
Open in API
Filings indexed 323 across all filing types
Latest filing 2021-10-25 Regulatory Filings
Country US United States of America
Listing US AURA

About Aura Biosciences, Inc.

https://aurabiosciences.com/

Aura Biosciences is a clinical-stage biotechnology company developing a new class of targeted therapies for solid tumors. The company's proprietary platform creates Virus-Like Drug Conjugates (VDCs), which use Virus-Like Particles to selectively deliver anti-cancer agents to tumor cells. This approach is designed to destroy cancer while preserving healthy tissue and organ function. Aura's initial focus is on ocular and urologic oncology, with a lead program for the first-line treatment of choroidal melanoma, a rare, vision-threatening eye cancer that lacks approved drug therapies. The company aims to establish a new standard of care across multiple cancer indications.

Recent filings

Filing Released Lang Actions
S-1/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC by Aura Biosciences, Inc. The Form S-1 is a registration statement used for initial public offerings (IPOs) and other securities offerings. The text includes details about the offering, company overview, risk factors, use of proceeds, management discussion, and other typical sections of a registration statement prospectus. It is not an annual report, earnings release, or any other financial report type. It is a regulatory filing related to securities registration and offering. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial (15,000 characters), and it is not merely an announcement or certification but the actual registration statement amendment filing text.
2021-10-25 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or references to specific report types, fiscal periods, or regulatory bodies. There is no indication that this is a report itself or an announcement of a report. Due to the lack of identifiable information and the fallback rule for documents that do not fit any specific category, the appropriate classification is Regulatory Filings (RNS). The document length is 15,000 characters, which is substantial, but without meaningful content, it cannot be classified as a financial or other specific report type.
2021-10-13 English
Regulatory Filings 2021
Regulatory Filings Classification · 100% confidence The document is a letter from the company's legal counsel responding to comments from the SEC staff regarding a Draft Registration Statement on Form S-1. It references amendments to the Draft Registration Statement, responses to SEC comments, and details about the Registration Statement filing. The document is correspondence related to the registration process for a securities offering, specifically an S-1 registration statement, which is a filing for an initial public offering or other securities registration. This is not the registration statement itself, nor is it a financial report or earnings release. It is a regulatory correspondence filing responding to SEC comments on a registration statement. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement and correspondence with the SEC that does not fit other specific categories.
2021-10-08 English
S-1
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a detailed registration statement for an initial public offering (IPO) of common stock by Aura Biosciences, Inc. The text includes the SEC header, registration details, offering information, risk factors, business overview, management discussion, financial data summary, and other disclosures typical of an S-1 filing. This type of document is a regulatory filing used to register securities for public sale and is not an annual report, earnings release, or other financial report. The S-1 registration statement is a capital markets filing related to financing and securities offering. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-10-08 English
Regulatory Filings 2021
Regulatory Filings Classification · 95% confidence The provided document text appears to be heavily encoded or corrupted, containing mostly non-readable characters and no discernible financial, regulatory, or corporate filing content. There are no clear indications of report titles, fiscal periods, regulatory bodies, or keywords that would allow classification into any specific filing category. The document length is 15,000 characters, which is substantial, but the content does not contain meaningful text to identify it as a financial report or announcement. Given the lack of identifiable content and the fallback rule, the document should be classified as a Regulatory Filing (RNS), which serves as a catch-all category for filings that do not fit other specific types.
2021-09-27 English
Regulatory Filings 2021
Regulatory Filings
2021-09-21 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.